EMEA-003340-PIP01-22
Submitted by Anonymous (not verified) on 7 March 2024 - 8:34
EMEA-003340-PIP01-22
Opinions and letters of support on the qualification of novel methodologies for medicine development
Submitted by Anonymous (not verified) on 7 March 2024 - 8:32
Opinions and letters of support on the qualification of novel methodologies for medicine development
Human medicines European public assessment report (EPAR): Apealea, paclitaxel, Date of authorisation: 20/11/2018, Revision: 7, Status: Withdrawn
Submitted by Anonymous (not verified) on 6 March 2024 - 16:27
Human medicines European public assessment report (EPAR): Apealea, paclitaxel, Date of authorisation: 20/11/2018, Revision: 7, Status: Withdrawn
DARWIN EU data partners onboarded in phases I and II
Submitted by Anonymous (not verified) on 6 March 2024 - 14:10
DARWIN EU data partners onboarded in phases I and II
DARWIN EU: Making health data count
Submitted by Anonymous (not verified) on 6 March 2024 - 14:03
DARWIN EU: Making health data count
DARWIN EU® continues expanding its capacity to deliver real-world data studies
Submitted by Anonymous (not verified) on 6 March 2024 - 14:00
DARWIN EU® continues expanding its capacity to deliver real-world data studies
List of signals discussed at PRAC since September 2012
Submitted by Anonymous (not verified) on 6 March 2024 - 10:54
List of signals discussed at PRAC since September 2012
PRAC recommendations on signals adopted at the 5-8 February 2024 PRAC meeting
Submitted by Anonymous (not verified) on 6 March 2024 - 10:49
PRAC recommendations on signals adopted at the 5-8 February 2024 PRAC meeting
Herbal medicinal product: Silybi mariani fructusArray, F: Assessment finalised
Submitted by Anonymous (not verified) on 5 March 2024 - 16:06
Herbal medicinal product: Silybi mariani fructusArray, F: Assessment finalised
Minutes of the PRAC meeting 8-11 January 2024
Submitted by Anonymous (not verified) on 5 March 2024 - 15:42
Minutes of the PRAC meeting 8-11 January 2024